Edgestream Partners L.P. Acquires New Shares in Amedisys, Inc. (NASDAQ:AMED)

Edgestream Partners L.P. bought a new position in Amedisys, Inc. (NASDAQ:AMED - Free Report) in the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 48,347 shares of the health services provider's stock, valued at approximately $4,666,000. Edgestream Partners L.P. owned approximately 0.15% of Amedisys at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. SG Americas Securities LLC grew its position in Amedisys by 41.6% in the 2nd quarter. SG Americas Securities LLC now owns 38,315 shares of the health services provider's stock worth $3,517,000 after purchasing an additional 11,264 shares in the last quarter. Dimensional Fund Advisors LP grew its holdings in shares of Amedisys by 4.0% in the second quarter. Dimensional Fund Advisors LP now owns 514,166 shares of the health services provider's stock valued at $47,202,000 after acquiring an additional 19,660 shares in the last quarter. California State Teachers Retirement System increased its position in shares of Amedisys by 65.8% during the first quarter. California State Teachers Retirement System now owns 54,592 shares of the health services provider's stock valued at $5,031,000 after acquiring an additional 21,671 shares during the last quarter. Cetera Advisors LLC bought a new stake in Amedisys during the first quarter worth $1,556,000. Finally, Murchinson Ltd. boosted its position in Amedisys by 69.2% in the second quarter. Murchinson Ltd. now owns 123,979 shares of the health services provider's stock worth $11,381,000 after purchasing an additional 50,716 shares during the last quarter. Hedge funds and other institutional investors own 94.36% of the company's stock.

Amedisys Stock Performance

Shares of Amedisys stock traded up $0.18 during trading hours on Friday, hitting $91.41. 107,958 shares of the company's stock traded hands, compared to its average volume of 580,939. The stock has a market capitalization of $2.99 billion, a price-to-earnings ratio of 36.27, a PEG ratio of 1.92 and a beta of 0.78. Amedisys, Inc. has a 12-month low of $88.81 and a 12-month high of $98.95. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.19 and a quick ratio of 1.19. The company has a fifty day simple moving average of $94.74 and a 200-day simple moving average of $95.62.

Amedisys (NASDAQ:AMED - Get Free Report) last posted its quarterly earnings data on Wednesday, November 6th. The health services provider reported $1.00 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.19 by ($0.19). The company had revenue of $587.67 million for the quarter, compared to analysts' expectations of $586.75 million. Amedisys had a return on equity of 12.20% and a net margin of 3.57%. The business's quarterly revenue was up 5.7% on a year-over-year basis. During the same quarter last year, the business posted $0.98 EPS. Equities research analysts anticipate that Amedisys, Inc. will post 4.55 EPS for the current fiscal year.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.